Patients researching semaglutide, medical weight loss, and GLP-1 therapy are asking AI for provider recommendations. AEO puts your practice in those answers.
Medical weight loss — particularly semaglutide and GLP-1 therapy — is one of the fastest-growing segments in aesthetic medicine. Demand is surging and patients are actively researching providers using AI tools to find who offers these treatments in their area.
The weight loss practice that appears in ChatGPT or Perplexity answers about semaglutide or medically supervised weight loss in their market is capturing first-mover advantage in an extraordinarily high-demand space.
We implement AEO for medical weight loss practices covering semaglutide, tirzepatide, GLP-1 therapy, medically supervised programs, and body contouring combined with weight loss.
Medical weight loss GEO is a first-mover opportunity right now. Demand for semaglutide and GLP-1 therapy is surging and patients are actively asking generative AI tools which providers offer these treatments. Almost no medical weight loss practices have implemented GEO, making this one of the highest-ROI AI search opportunities available.
FAQPage, MedicalOrganization, and Speakable schema implemented across every page so AI engines can extract and serve your content as direct answers.
Consistent NAP signals, directory citations, and entity optimization so ChatGPT and Perplexity recognize your practice as a trusted local authority.
robots.txt and llms.txt configured to invite GPTBot, PerplexityBot, ClaudeBot, and Google-Extended so AI systems can fully index your content.
Service pages and blog content restructured into question-and-answer format that AI engines are designed to surface as direct recommendations.
Direct submission to the Perplexity Publishers program for prioritized inclusion in Perplexity AI recommendations.
Sitemap submission to Bing Webmaster Tools since ChatGPT pulls browsing results from Bing — critical for ChatGPT visibility.
AEO gets your medical weight loss practice recommended by AI tools when patients in your area ask about semaglutide, Ozempic, Wegovy, or medical weight loss programs. Demand for these treatments is high and AI tool recommendations drive high-quality, motivated patient inquiries.
Semaglutide and tirzepatide programs benefit most due to the volume of AI searches. Medically supervised weight loss programs, GLP-1 therapy, and combined body contouring services are strong secondary priorities.
Currently less competitive than traditional SEO for weight loss keywords. Most medical weight loss practices have not yet optimized for AI search, creating a first-mover opportunity that compounds over time.
You may see this discipline called either Answer Engine Optimization (AEO / GEO) (AEO) or Generative Engine Optimization (GEO) depending on who you ask. Both terms describe the same practice: structuring your digital presence so AI-powered tools like ChatGPT, Perplexity, and Google AI Overviews surface your practice as a recommended answer when patients ask questions.
GEO was coined in academic research at Stanford in 2023 and tends to be used by larger enterprise agencies. AEO is the more widely used practitioner term. At Medical Marketing Firm we use both interchangeably — what matters is the outcome: your practice showing up in AI answers before competitors do.
Whether you search for AEO services, GEO services, or AI search optimization for medical practices, you are looking for the same thing. We deliver it exclusively for cosmetic and aesthetic practices.
Free AEO audit. No contracts. 30-day free trial.
Get My Free AEO Audit →